Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model.
about
Ginsenosides from American ginseng: chemical and pharmacological diversityNew Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of AutophagyPlant-derived neuroprotective agents in Parkinson's diseaseNeuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury.Effects of Panax ginseng in Neurodegenerative Diseases.A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials.Ginsenosides and their CNS targets.Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.Neuroprotection by saponins.Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson's disease.Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats.Shengmai injection attenuates the cerebral ischemia/reperfusion induced autophagy via modulation of the AMPK, mTOR and JNK pathways.Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.Linking biological activity with herbal constituents by systems biology-based approaches: effects of Panax ginseng in type 2 diabetic Goto-Kakizaki rats.Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
P2860
Q24630142-41103493-DE94-4526-AF05-54758DD7F46CQ26753053-E7D32BCF-DBFA-4EF1-BDBB-CCA363B9F23FQ26795546-E4B8508F-67C6-4A41-AF59-B9F86B8CF48EQ36722089-330BD104-36C3-4197-8EC6-3CD72F2B665AQ36861205-C7070D79-ACAA-4C3D-BA02-8D6708A8A338Q37195895-77A0305B-3112-4EE6-AF3C-DFC8AA978604Q37818509-3DD0D0BD-0B1F-4039-8FB6-B8056218B246Q38263144-8A8B91E1-0650-441C-8ACC-1F8999E84A1BQ38269464-5CE1524D-1F4B-422D-BCC8-FC7C2FDB9C4FQ38927155-B3050FA5-0A36-4F32-8834-33DE6C19B3F5Q38950941-8B832D5B-767B-4841-B184-BD207D4BA3C7Q42707394-0D79E31C-79DE-415F-82B3-F61F9141F07AQ46606547-61B7CF9C-5FF3-485B-9944-221E49C0DBC3Q47326098-D8556ADC-BEAD-4B6D-9169-1678AF2EEC39Q47855005-0D9C7CD0-EFCB-4803-BE51-C62FFCBD9644Q51368612-B170246E-5224-47D8-A04B-CCC5C9E06F34Q53082241-8AC991A5-D8BD-4F4D-9726-DA71687EAA47
P2860
Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@ast
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@en
type
label
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@ast
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@en
prefLabel
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@ast
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@en
P2093
P2860
P1476
Possible mechanisms of the pro ...... rkinson's disease mouse model.
@en
P2093
Bei-Bei Xu
Chun-Qing Liu
Shi-Wei Wang
Wan-Qin Zhang
Ying-Lin Cao
P2860
P304
P356
10.1080/10286020410001690172
P577
2005-06-01T00:00:00Z